Le Lézard
Classified in: Health
Subject: FDA

Nanobionic® USA Announces FDA Registration


Nanobionic® Award-Winning Innovative Technology is a Game-Changer for Textiles

NEW YORK, March 7, 2018 /CNW/ -- Nanobionic® USA announces today, that their products are regulated by the U.S Food & Drug Administration (FDA) as medical devices and general wellness products, as defined in Section 201(h) of the Food, Drug and Cosmetic Act. Nanobionic® USA is FDA registered, and several Nanobionic® products are listed with the FDA as medical devices.

Nanobionic® technology is a high-tech patented coating that releases Far Infrared Rays (FIR) to the body. Far Infrared Rays (FIR) are invisible waves of energy that have the ability to penetrate, sooth and stimulate the human body.

Nanobionic® technology is the world's most advanced Far infrared technology on the market, that delivers up to 99 percent of Far Infrared emissivity, which is the most beneficial to the human body.

Nanobionic® is a unique clinically proven patented technology that is applied to various textiles in bedding, apparel (active-wear, sportswear, military), and health care sectors, to name a few. All textiles that are treated with Nanobionic® technology offer the benefit of the safe and effective natural Far Infrared (FIR) energy to the body, which has been proven to stimulate local blood flow, delivering oxygen and vital nutrients to cells.

When applied to bedding products, it stimulates local blood flow, helps reduce cold hands and feet, promotes restful and quality of sleep, increases faster recovery and enhances overall wellness of being.

When applied to apparel it stimulates local blood flow, improves athletic performance, boosts energy, increases strength and endurance, enhances faster recovery, reduces fatigue, and increases general wellness of being.

Nanobionic® USA's Founder & CEO, George Psipsikas, said: "We have tirelessly worked to perfect our technology and applied it to products that people use in their daily life, becoming a game changer on how people will be benefiting from clothing, bedding and various other products to improve their life."

A recent breakthrough study also showed that Nanobionic® technology can reduce Free Radicals and Oxidative Stress on a cellular level. This is the first time ever that clinical studies have proven that fabrics (textiles) can provide such benefits to the human body, concluding that the application possibilities are endless.

Nanobionic® technology has received 12 international awards for innovation, and is the next generation in bio-functional textiles, combining science, technology and nature to enhance your life.

Technology & Product Information: www.nanobionic-group.com

Media Contact:
SUCCESS PLAN MEDIA
[email protected]

Related Links

NANOBIONIC GROUP

SUCCESS PLAN MEDIA

SOURCE Nanobionic® USA


These press releases may also interest you

at 07:35
Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced...

at 07:35
Accuray Incorporated announced today that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife® and Radixact® platforms provide medical care...

at 07:30
Jushi Holdings Inc. ("Jushi" or the "Company") , a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first quarter ended March 31, 2024, after the market closes on Thursday, May...

at 07:30
Ziosoft, a pioneer in 3D/4D AI medical visualization, will feature its unique REVORAS-enabled thoracic surgical planning capabilities at the annual American Association of Thoracic Surgeons (AATS) conference being held April 27 - 29, 2024 in Toronto,...

at 07:30
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received notice of intent...

at 07:25
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation ("the Gates Foundation" or "the...



News published on and distributed by: